We found significantly greater baseline and cytokine stimulated proliferation in CML CD34+ cells in comparison to control CD34+ cells (p<0.001, n=3) (Figure 6C). The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.